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W orld Kidney Day is anappropriate time to reﬂect
on the epidemics(s) of chronic
kidney disease (CKD) of undeter-
mined cause (CKDu) that are
affecting agricultural communities in
Central America, South Asia, and
possibly other parts of the world.1–4
The cause(s) of CKDu remain to be
established, with heat, pesticides,
water (including heavy metals), in-
fections, or other factors being sug-
gested as the primary cause(s).
However, we still do not know, at
least on a global level, who gets this
disease, or even if the disease is the
same in different parts of the world.
This lack of basic epidemiological
information also has important im-
plications for health care. World
Kidney Day 2019 has a theme of
“health care access for all,” but
health care access cannot be pro-
vided for a disease that is
unrecognized, undiagnosed, and
(even when diagnosed) often un-
treated. CKDu is clinically silent in
the early stages and, in many of
the affected areas, carries a poor
prognosis. It is usually diagnosed
late, and no data are available on
factors predicting progression.
Renal replacement therapy is un-
available in many low- and
middle-income countries,5 and
even if present, it is often inacces-
sible to most of the population,
meaning that end-stage renal dis-
ease is usually fatal. In addition
to the young lives lost, CKDu has
a substantial negative impact on
social and economic development
of affected countries, through jeop-
ardizing the economic development
of the affected communities, and
straining the poorly resourced
health systems of the affected
countries.
What Is CKDu and Who Gets
It?
The common clinical features of
CKDu are impaired kidney function
in the absence of diabetes, evidence
of primary glomerulonephritis
(either on renal biopsy or clinically),
or structural abnormality. The
limited number of kidney biopsies
performed in affected persons show
scarring of a type that might be the
consequence of a wide range of
insults.6
Although there have been
numerous case reports, it is only
now that evidence from population-
based surveys is beginning to
emerge showing that CKDu exists in
India and Sri Lanka,7,8 in addition to
Central America.1,9–11 It also may be
occurring in other tropical/subtrop-
ical parts of the world, including
Saudi Arabia,12 Egypt,13 and
Senegal,14 but standardized data are
not available for comparison. Valid
comparisons cannot be made using
renal replacement therapy registry
data because of varying access.
Therefore, valid prevalence esti-
mates can currently be obtained
only by identifying renal impair-
ment in random population surveys.
Thus, we have recently established a
partnership that has developed a
common protocol to estimate distri-
butions of renal function in disad-
vantaged communities globally: the
Disadvantaged populations esti-
mated glomerular ﬁltration rate
epidemiology study (DEGREE).15
What Does the Article by
Tatapudi et al. Add?
The article by Tatapudi et al.16 of a
population-based survey in the
Uddanam region of Andhra Pradesh
in India, in this issue of the journal,
is a welcome addition to the litera-
ture on CKDu. It adds to other
recent evidence from population-
based surveys in India17 and Sri
Lanka,8 and conﬁrms that CKDu
occurs in South Asia as well as in
Central America. The importance of
this should not be underestimated.
It is only by population-based
studies of this type that we can
really know who gets this disease
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globally; this is not only crucial in
public health and clinical terms, but
is also an essential ﬁrst step in
discovering the causes of CKDu.
Before discussing the ﬁndings,
several limitations of the study
should be noted. As with all cross-
sectional studies of this type,15 it
is not measuring the prevalence of
CKDu, because it involves a “one-
off” measurement of eGFR, whereas
2 measurements are required to
conﬁrm the chronicity of any form
of CKD. A related issue is that eGFR
calculated from serum creatinine is
a function of ethnicity18 and can
also vary with exercise, muscle
mass, and meat consumption. In
particular, it has been previously
suggested that we are likely to
overestimate kidney function in
South Asian individuals,18,19 and
therefore that prevalence estimates
in India and Sri Lanka may be
falsely low. However, although
these are issues for clinical diag-
nosis, and for comparisons between
different regions of the world, they
are unlikely to be major issues in
subgroup comparisons within a
particular region.15 Perhaps a more
signiﬁcant issue is that Tatapudi
et al.16 appear to provide no infor-
mation on the calibration of creati-
nine, and their deﬁnitions of key
biomarkers are somewhat nonstan-
dard (e.g., the protein-creatinine
ratio cutoff of 0.2, the deﬁnition of
“long-standing hypertension,”
which requires this to have existed
for more than 5 years); these issues
may lead to the inclusion of some
patients with glomerulonephritis or
other known causes of CKD, thus
overestimating the prevalence of
true CKDu. For example, in the Sri
Lankan surveys,8 the prevalence of
“suspected CKDu” dropped from
10.7% to 6.7% when more restric-
tive exclusions for hypertension
were used. A further concern is that
the sampling methodology does not
clearly indicate whether population
enumeration was carried out, the
criteria used for deﬁning the sam-
pling frame, and the sampling pro-
cedures. The concern is that there
may be greater participation from
those affected with CKD, which
may lead to prevalence being over-
estimated. These methodological is-
sues are unlikely to bias subgroup
comparisons, but they do make
comparisons with other studies in
the same region8,17 more difﬁcult.
So apart from conﬁrming the
presence of CKDu, what else does
the study of Tatapudi et al.16
contribute? As with other compa-
rable studies,8,17 the prevalence of
CKD in general, and CKDu in
particular, increases markedly with
age. It is noteworthy that a high
proportion of the participants had
hypertension, diabetes, or protein-
uria, in contrast with CKDu hotspots
in Central America, and therefore it
is more challenging to separate
CKDu from CKD in this setting.
Although CKDu is associated
with agricultural work, it is not
particularly strongly associated
with farming (odds ratio 1.39) or
with pesticide use (odds ratio 0.85),
unlike many studies in Sri Lanka.20
The authors conjecture that “there
might be a new etiological factor or
multiple factors responsible.”
This is similar to ﬁndings in
other cross-sectional studies in
South Asia8,17 and Central Amer-
ica,21 which consistently ﬁnd that
increased risks, if they exist, occur
primarily (but not exclusively) in
agricultural populations, but that
these do not seem to be clearly
linked to exposures such as heat
stress or pesticides.9 This may
reﬂect the absence of any causal
association, inadequacies with the
exposure questions used, or the
more general inadequacies of cross-
sectional studies. In fact, a study in
Central America21,22 involved
follow-up (after an initial cross-
sectional study), and identiﬁed a
distinct subgroup experiencing
rapid decline in kidney function,
although the risk factors for this
decline were still difﬁcult to
identify.
Where Next for CKDu?
So where next for CKDu? There are
2 immediate conclusions that can
be drawn from the study of Tata-
pudi et al.16
First, it is urgent to discover
which parts of the world are expe-
riencing endemic/epidemic CKDu.
In some commentaries there have
been assumptions that the condition
is either conﬁned to a particular
area, with local risk factors playing
a key role (hence the use of “local”
names, such as Meso-American ne-
phropathy23 or Uddanam nephrop-
athy24), or that there is a global
epidemic with common risk factors
across regions.25 The reality is that
no one knows, and that global
health policy cannot be based on
anecdotal reports of individual
cases, particularly for a “disease of
exclusion,” such as CKDu, where
there is always a risk that apparent
cases of CKD may in fact be due to
undiagnosed diabetes or other
established causes of kidney disease.
What is required is population sur-
veys in different parts of the world
using standardized methods.15 Until
these have been done, we cannot
say more than that CKDu exists in
Central America and South Asia,
but that we cannot say much
about the rest of the world.
Perhaps there is a global epidemic
that will require major health
system resources and raise major
issues of “health care access for
all,” or perhaps these are regional
rather than global problems. We
simply do not know. We need
more surveys and publications
like that of Tatapudi et al.16
Second, although prevalence
surveys are an essential ﬁrst step,
they need to be followed by more
intensive cohort studies in “at-
risk” populations,21,22 as recom-
mended by Tatapudi et al.16 It is
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only through more intensive data
collection of this type that we can
make progress on discovering the
cause(s) of CKDu, and whether the
“epidemics” in Central America
and South Asia involve common
causes, or separate local causes.
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